Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · lyophilized powder, vial

Epic Peptides Lab · USA

Document number: PL-SDS-157
Revision: 1.1 · 2026-11-10

SUPER Human Blend (eight free amino acids)

lyophilized powder, vial

1Identification

Product Identifier

Document Number

PL-SDS-157

Catalogue Items Covered

Id
2283
Name
Pryma SUPER Human Blend
Sku
PL-SUPERHUMAN-BLD

Recommended Use

Laboratory research use by trained personnel.

Restrictions On Use

Not for human or veterinary use.

Supplier / Distributor

Epic Peptides Lab, USA

Telephone

+1 (787) 468-5291

info@epicpeptideslab.com

2Hazard(s) identification

Classification: Not classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Label Elements: No data available.
Signal Word: No data available.
Other Hazards: No data available.

3Composition / information on ingredients

Description

Lyophilized (freeze-dried) powder or cake in a sealed glass vial with a rubber stopper and aluminium crimp cap.

Composition

Name
L-Carnitine
Full
Levocarnitine (inner salt); small molecule, not a peptide
Cas
541-15-1
Formula
C7H15NO3
Conc
27.8%
Qty
220 mg per vial
Name
L-Citrulline
Full
L-Citrulline
Cas
372-75-8
Formula
C6H13N3O3
Conc
15.2%
Qty
120 mg per vial
Name
L-Arginine
Full
L-Arginine
Cas
74-79-3
Formula
C6H14N4O2
Conc
13.9%
Qty
110 mg per vial
Name
L-Ornithine
Full
L-Ornithine (as hydrochloride)
Cas
70-26-8
Formula
C5H12N2O2
Conc
13.9%
Qty
110 mg per vial
Name
L-Lysine
Full
L-Lysine (as hydrochloride)
Cas
56-87-1
Formula
C6H14N2O2
Conc
8.9%
Qty
70 mg per vial
Name
L-Proline
Full
L-Proline
Cas
147-85-3
Formula
C5H9NO2
Conc
7.6%
Qty
60 mg per vial
Name
Taurine
Full
Taurine
Cas
107-35-7
Formula
C2H7NO3S
Conc
7.6%
Qty
60 mg per vial
Name
L-Glutamine
Full
L-Glutamine
Cas
56-85-9
Formula
C5H10N2O3
Conc
5.1%
Qty
40 mg per vial

4First-aid measures

First Aid Measures

Inhalation: Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.

Most Important Symptoms And Effects

No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

Likely Routes Of Exposure

Inhalation of dust, skin and eye contact when the vial is opened or the powder is weighed; ingestion through contaminated hands; accidental injection when reconstituted solutions are drawn into syringes.

5Fire-fighting measures

Fire Fighting Information: Combustible organic solid; finely divided powder may form dust clouds. Not flammable in the quantities supplied.

6Accidental release measures

Spill And Clean Up Procedures: Avoid dust formation. Dampen spilled powder with water, wipe up with absorbent material, place in a sealed container for disposal and clean the area with water and detergent.

7Handling and storage

Safe Handling: Open vials only in a clean area. Avoid generating or inhaling dust; weigh or reconstitute inside a ventilated enclosure when the full contents are handled as a dry powder. Reconstitute by adding diluent slowly to the vial wall; do not shake. Wash hands after handling.
Safe Storage: Store the sealed vial at the temperature stated in Section 9 (typically −20 °C for peptides, 2–8 °C for proteins), desiccated and protected from light. Allow the vial to reach room temperature before opening to avoid condensation. Reconstituted solutions: 2–8 °C, protected from light; use within the period established by your laboratory.
Storage Temperature: −20 °C (sealed vial), desiccated and protected from light; 2–8 °C acceptable for short periods
Incompatible Materials: Strong oxidizing agents (Spectrum, ChemicalBook)

8Exposure controls / personal protection

Occupational Exposure Limits: No data available.
Exposure Controls And PPE: No data available.

9Physical and chemical properties

Physical State

Solid

Appearance

White to off-white lyophilized powder or cake

Properties

Odor: No information available
Ph: Not applicable (solid); aqueous solutions typically pH 4–7
Melting: 197-212 °C (Spectrum; Sigma lit.; ChemicalBook)
Boiling: No information available (287.5 °C rough estimate, ChemicalBook)
Flash: Not applicable (non-flammable solid); combustible organic material
Vapour: Negligible (solid)
Density: No data available (bulk density of lyophilized cake is low)
Solubility: Soluble in water, ca. 100 g/L at 20 °C (ChemicalBook); insoluble in acetone, benzene, ether (Spectrum)
Logp: No data available
Decomp: No data available; peptides decompose above about 200 °C
Other: Inner salt (zwitterion), MW 161.20; Sigma storage class 11 (combustible solids); flash point not applicable; TCI: store under inert gas, hygroscopic

10Stability and reactivity

Stability And Reactivity

Reactivity: Stable under recommended storage conditions
Incompatible: Strong oxidizing agents (Spectrum, ChemicalBook)
Decomposition: Carbon monoxide, carbon dioxide, nitrogen oxides (NOx) (Spectrum, ChemicalBook)
Conditions To Avoid: Heat, dust formation, incompatible materials (Spectrum); moisture - hygroscopic (ChemicalBook, TCI)

Conditions To Avoid

Heat, dust formation, incompatible materials (Spectrum); moisture - hygroscopic (ChemicalBook, TCI); No information available (SDS); generic: heat, moisture, dust formation; Dust formation / ignition sources for finely divided powder; moisture (hygroscopic); Moisture (hygroscopic), high temperature

Incompatible Materials

No data available.

11Toxicological information

Toxicological Information: Acute toxicity, oral
LD50 oral, rat: > 5000 mg/kg; LD50 oral, rabbit: > 5000 mg/kg (ChemicalBook/Sigma-type); LD50 oral, mouse: 19.2 g/kg (Spectrum)

Acute toxicity, dermal
No information available

Acute toxicity, inhalation
No information available

Skin corrosion/irritation
Causes skin irritation (Spectrum, Cat. 2); no data / not classified (Sigma-type)

Serious eye damage/irritation
Causes eye irritation (Spectrum, Cat. 2B); no data / not classified (Sigma-type)

Respiratory or skin sensitisation
No information available

Germ cell mutagenicity
No information available

Carcinogenicity
Not considered carcinogenic (Spectrum); no IARC-identified carcinogen at >=0.1% (ChemicalBook); not listed by NTP, OSHA, Prop 65

Reproductive toxicity
No data available

STOT, single exposure
Irritating to respiratory system (Spectrum, Cat. 3); not classified (Sigma-type)

STOT, repeated exposure
No data available

Aspiration hazard
No data available
Routes Of Exposure: Inhalation of dust, skin and eye contact when the vial is opened or the powder is weighed; ingestion through contaminated hands; accidental injection when reconstituted solutions are drawn into syringes.
Symptoms: No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

12Ecological information

Ecological Information: No ecotoxicity, persistence, bioaccumulation or mobility data available (Spectrum, ChemicalBook). Expected readily biodegradable.

13Disposal considerations

Disposal Guidance: No data available.

14Transport information

Transport Classification

Note: Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information

Tsca: Not listed (Spectrum; ChemicalBook) - verify against current inventory
Carcinogen Listings: Not listed (IARC, NTP, OSHA, California Prop 65)
Dea: Not a controlled substance
Other: FDA: present, not regulated under 21 CFR (Spectrum); EINECS and China IECSC listed; not Korea KECL. WADA remark: not prohibited (but intravenous infusions >100 mL per 12 h are a prohibited method M2).

Carcinogen Listings

No data available.

16Other information

Revision: November 10, 2026
Sources Consulted: Spectrum Chemical

ChemicalBook

Sigma-Aldrich

TCI

ChemicalBook-hosted SDS

Sigma-Aldrich / Merck

NeoFroxx GmbH

Duchefa Biochemie

Fisher Scientific

Acros Organics / Fisher

BioSpectra
Confidence: medium
Additional Information: Spectrum classifies the substance as a skin, eye and respiratory irritant; Sigma-Aldrich does not (oral LD50 rat > 5,000 mg/kg). Sigma-Aldrich is followed.

Back to SDS list